BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20375200)

  • 1. Generation of a mouse model with a reversible hypomorphic cytochrome P450 reductase gene: utility for tissue-specific rescue of the reductase expression, and insights from a resultant mouse model with global suppression of P450 reductase expression in extrahepatic tissues.
    Wei Y; Zhou X; Fang C; Li L; Kluetzman K; Yang W; Zhang QY; Ding X
    J Pharmacol Exp Ther; 2010 Jul; 334(1):69-77. PubMed ID: 20375200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model with liver-specific deletion and global suppression of the NADPH-cytochrome P450 reductase gene: characterization and utility for in vivo studies of cyclophosphamide disposition.
    Gu J; Chen CS; Wei Y; Fang C; Xie F; Kannan K; Yang W; Waxman DJ; Ding X
    J Pharmacol Exp Ther; 2007 Apr; 321(1):9-17. PubMed ID: 17218484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450.
    Wu L; Gu J; Cui H; Zhang QY; Behr M; Fang C; Weng Y; Kluetzman K; Swiatek PJ; Yang W; Kaminsky L; Ding X
    J Pharmacol Exp Ther; 2005 Jan; 312(1):35-43. PubMed ID: 15328377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase.
    Gu J; Weng Y; Zhang QY; Cui H; Behr M; Wu L; Yang W; Zhang L; Ding X
    J Biol Chem; 2003 Jul; 278(28):25895-901. PubMed ID: 12697746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic gene expression changes in mouse models with liver-specific deletion or global suppression of the NADPH-cytochrome P450 reductase gene. Mechanistic implications for the regulation of microsomal cytochrome P450 and the fatty liver phenotype.
    Weng Y; DiRusso CC; Reilly AA; Black PN; Ding X
    J Biol Chem; 2005 Sep; 280(36):31686-98. PubMed ID: 16006652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of renal proximal tubule P450 enzymes in chloroform-induced nephrotoxicity: utility of renal specific P450 reductase knockout mouse models.
    Liu S; Yao Y; Lu S; Aldous K; Ding X; Mei C; Gu J
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):230-7. PubMed ID: 23732084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional knockout of the mouse NADPH-cytochrome p450 reductase gene.
    Wu L; Gu J; Weng Y; Kluetzman K; Swiatek P; Behr M; Zhang QY; Zhuo X; Xie Q; Ding X
    Genesis; 2003 Aug; 36(4):177-81. PubMed ID: 12929087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice.
    Weng Y; Fang C; Turesky RJ; Behr M; Kaminsky LS; Ding X
    Cancer Res; 2007 Aug; 67(16):7825-32. PubMed ID: 17699788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase.
    Henderson CJ; Otto DM; Carrie D; Magnuson MA; McLaren AW; Rosewell I; Wolf CR
    J Biol Chem; 2003 Apr; 278(15):13480-6. PubMed ID: 12566435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo mechanisms of tissue-selective drug toxicity: effects of liver-specific knockout of the NADPH-cytochrome P450 reductase gene on acetaminophen toxicity in kidney, lung, and nasal mucosa.
    Gu J; Cui H; Behr M; Zhang L; Zhang QY; Yang W; Hinson JA; Ding X
    Mol Pharmacol; 2005 Mar; 67(3):623-30. PubMed ID: 15550675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive hepatic and intestinal alterations in mice after deletion of NADPH-cytochrome P450 Oxidoreductase (Cpr) in hepatocytes.
    Cheng X; Gu J; Klaassen CD
    Drug Metab Dispos; 2014 Nov; 42(11):1826-33. PubMed ID: 25147274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites.
    He Y; Lian W; Ding L; Fan X; Ma J; Zhang QY; Ding X; Lin G
    Arch Toxicol; 2021 Jan; 95(1):103-116. PubMed ID: 33033841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of intestinal cytochrome P450 expression by hepatic cytochrome P450: possible involvement of fibroblast growth factor 15 and impact on systemic drug exposure.
    Zhu Y; Ding X; Fang C; Zhang QY
    Mol Pharmacol; 2014 Jan; 85(1):139-47. PubMed ID: 24184963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase.
    Li L; Porter TD
    Arch Biochem Biophys; 2007 May; 461(1):76-84. PubMed ID: 17374357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.
    Stiborová M; Arlt VM; Henderson CJ; Wolf CR; Kotrbová V; Moserová M; Hudecek J; Phillips DH; Frei E
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):318-27. PubMed ID: 17976674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased bile-acid synthesis in livers of hepatocyte-conditional NADPH-cytochrome P450 reductase-null mice results in increased bile acids in serum.
    Cheng X; Zhang Y; Klaassen CD
    J Pharmacol Exp Ther; 2014 Oct; 351(1):105-13. PubMed ID: 25034404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the NADPH-cytochrome P450 reductase gene in cardiomyocytes does not protect mice against doxorubicin-mediated acute cardiac toxicity.
    Fang C; Gu J; Xie F; Behr M; Yang W; Abel ED; Ding X
    Drug Metab Dispos; 2008 Aug; 36(8):1722-8. PubMed ID: 18463197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine.
    Zhang QY; Fang C; Zhang J; Dunbar D; Kaminsky L; Ding X
    Drug Metab Dispos; 2009 Mar; 37(3):651-7. PubMed ID: 19056912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of small-intestinal P450 enzymes in protection against systemic exposure of orally administered benzo[a]pyrene.
    Fang C; Zhang QY
    J Pharmacol Exp Ther; 2010 Jul; 334(1):156-63. PubMed ID: 20400470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary regulation of mouse intestinal P450 expression and drug metabolism.
    Zhang P; Jia K; Fang C; Zhou X; Ding X; Zhang QY
    Drug Metab Dispos; 2013 Feb; 41(2):529-35. PubMed ID: 23160819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.